A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial seems to be testing a technology-based monitoring system for Parkinson's — things like measuring how many times I can repeat a movement and analyzing my walking patterns with a device — so can you explain what kinds of tests or wearable sensors would actually be involved, and whether the physical demands of repeated movement tasks are appropriate given my current condition?
2. 2Since this trial is listed as Phase NA, which often means it's focused on testing a diagnostic or monitoring tool rather than a treatment drug, can you help me understand whether participating would change my actual care in any way, or is it purely about collecting data to validate the technology?
3. 3The trial is currently recruiting both people with Parkinson's and healthy adults — does my specific stage or symptom profile make me a good fit to discuss with the research team, or would standard clinical monitoring serve me just as well right now?
4. 4The study appears to measure very detailed movement signals like gait timing, rotation speed, and accelerometer frequencies — how would that data be used, and would my doctor have access to the results in a way that could actually inform my treatment going forward?
5. 5Given that this is focused on early diagnosis and ongoing monitoring rather than a new drug or therapy, is there any risk to participating, and could being part of this study delay or interfere with starting other treatments I might need?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.